Cleared Traditional

K850727 - BHCG-ROCHE EIA

K850727 is the FDA 510(k) clearance for BHCG-ROCHE EIA by Hoffmann-La Roche, Inc.. It is a Class 2 Chemistry device (product code JHI) cleared through the Traditional 510(k) pathway after a 123-day FDA review.

K850727 · Hoffmann-La Roche, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1985
Decision
123d
Days
Class 2
Risk

K850727 is an FDA 510(k) clearance for the BHCG-ROCHE EIA. Classified as Visual, Pregnancy Hcg, Prescription Use (product code JHI), Class II - Special Controls.

Submitted by Hoffmann-La Roche, Inc. (Nutley, US). The FDA issued a Cleared decision on June 25, 1985 after a review of 123 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Hoffmann-La Roche, Inc. devices

Submission Details

510(k) Number K850727 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 22, 1985
Decision Date June 25, 1985
Days to Decision 123 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d slower than avg
Panel avg: 88d · This submission: 123d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JHI Visual, Pregnancy Hcg, Prescription Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHI Visual, Pregnancy Hcg, Prescription Use

All 186
Devices cleared under the same product code (JHI) and FDA review panel - the closest regulatory comparables to K850727.
AMERLEX-M B-HUMAN CHORIONIC GONADTROPIN RADIOI KIT
K852675 · Amersham Corp. · Jul 1985
BETA HCG EXTENDED RANGE ACCESSORY KIT
K852183 · Abbott Laboratories · Jul 1985
ECHOCLONAL HCG IRMA
K852201 · Bio-Rad · Jun 1985
PREGNA-ZYME
K850992 · Armkel, LLC · May 1985
MEDIX VISUAL URINE HCG (7/7) TEST
K850949 · Medix Biotech, Inc. · Apr 1985
MEDIX VISUAL SERUMO HCG L10/10 TEST HCG ENZYME IMM
K850987 · Medix Biotech, Inc. · Apr 1985